Rockwell Medical (NASDAQ:RMTI) Announces Quarterly Earnings Results

Rockwell Medical (NASDAQ:RMTI) announced its earnings results on Thursday. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04), Zacks reports. Rockwell Medical had a negative net margin of 1.25% and a positive return on equity of 8.55%. Rockwell Medical updated its FY 2025 guidance to EPS.

Rockwell Medical Stock Performance

Shares of Rockwell Medical stock traded down $0.34 on Thursday, reaching $1.43. 600,885 shares of the company were exchanged, compared to its average volume of 411,659. Rockwell Medical has a 1-year low of $1.34 and a 1-year high of $5.15. The firm has a market cap of $46.05 million, a price-to-earnings ratio of -28.30 and a beta of 1.55. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The company’s 50-day moving average is $1.88 and its two-hundred day moving average is $2.63.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. HC Wainwright reaffirmed a “buy” rating and set a $7.00 price target on shares of Rockwell Medical in a research report on Monday, December 23rd. StockNews.com downgraded Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.